Roy D. Baynes - Director at Atara Biotherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
ATRA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Roy D. Baynes since 9/18/2023

Holdings reported by Roy D. Baynes for Atara Biotherapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 43.5K $16.9K $0.39 Jun 23, 2022 Direct
Non-Qualified Stock Option (Right to Buy) 31.5K Jun 23, 2022 Direct Common Stock

Transactions reported by Roy D. Baynes for Atara Biotherapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.